Thursday, September 01, 2016
Tuesday, August 30, 2016
dealing with mesothelioma
Having mesothelioma can change many elements of a person's life, including physical appearance, emotional well-being and relationships with others.
My father suffered many physical changes such as weight loss, hair loss, and emotions took a toll on his mental state. His diagnosis also affected many of their relationships. Perhaps one of the most striking changes was the way people interacted with him after hearing the news of his cancer.
It may be irritating to hear someone you love is facing a disease, especially severe. When our family heard the news, we all reacted differently. My mom put a happy face for my dad, but when she was not hiding her emotions, she was visibly devastated.
My brother solemn show strength, while my sister avoided any show of emotion. Housework masked my fears and concerns.
As we are all different, our reaction to the disturbing news as a mesothelioma diagnosis will also vary. My family took the news in a different way. Dad diagnosis shook the whole family, but not separate us from him or each other.
The reactions of loved ones a mesothelioma diagnosis
people may react unexpectedly when hearing about a loved one has cancer. Understanding how the loved ones respond to the diagnosis of cancer can help patients to process people may exhibit behaviors.
Dad diagnosis shocked some of our relatives in silence. I do not call or visit. At the time, I did not understand why, and was angry with me.
But now I understand. Their reactions, then, what seems abnormal to me, were completely normal under the circumstances reality. When we are faced with situations that make us uncomfortable, some of us out of the situation as a whole. Others might behave awkwardly or act in a condescending manner.
The American Society of Clinical Oncology, identifies some of the ways family and friends might react to cancer.
Shock: Learning that someone close has cancer can be an unsettling reminder that can happen to anyone. While a diagnosis Most certainly shocks the person with the disease, some loved ones may experience similar emotions.
Painful memories: When someone who has experienced cancer personally or with a loved one, hear about a more recent diagnosis, can recover painful memories. The news can also scare them. Consider your reactions have more to do with his past experiences, not your personal path.
Overwhelmed & Amp; domineering: a cancer diagnosis can be overwhelming to family and friends with concerns, causing their hypervigilant. They may want to see more of you and help you at all times, even if you do not want or need your help.
Finding work through those first awkward encounters engages families and friends of the means of support and benefit for the road ahead. Good communication can help break through these behaviors.
Strong relationships are vital for the proper care of a loved one facing mesothelioma. Social withdrawal and isolation is detrimental to your emotional well-being. From my personal experience, with friends and loved ones for emotional support it is very comforting.
Steps to increase understanding & Amp; acceptance
instead of avoiding a loved one facing cancer, raising their level of acceptance and understanding is generally beneficial.
People who learn about a recent diagnosis loved being must understand some of the physical and emotional changes of patients may experience.
Knowing what to expect when visiting a person with cancer can relieve some stress and shock. The toll cancer in the body is evident shortly after diagnosis. Side effects of cancer treatments, such as alopecia and weight loss, drastically alter the physical appearance.
Because cancer also affects the patient's emotions, your loved one may behave differently than before.
The American Cancer Society offers some tips to ease the stress of the first encounters with recently diagnosed a loved one.
I do not advise your loved one, especially if they are not asking: knowledge and understanding about the disease your loved one does not make you an oncologist. Be respectful and support their decisions.
Do not avoid talking about the disease: cancer Talk about your loved one can travel directly help break the ice and soften it.
Not frequent: Adding an unusual "Honey" or "honey" to your verbal communication can destabilize your loved one. Try to talk and b
My father suffered many physical changes such as weight loss, hair loss, and emotions took a toll on his mental state. His diagnosis also affected many of their relationships. Perhaps one of the most striking changes was the way people interacted with him after hearing the news of his cancer.
It may be irritating to hear someone you love is facing a disease, especially severe. When our family heard the news, we all reacted differently. My mom put a happy face for my dad, but when she was not hiding her emotions, she was visibly devastated.
My brother solemn show strength, while my sister avoided any show of emotion. Housework masked my fears and concerns.
As we are all different, our reaction to the disturbing news as a mesothelioma diagnosis will also vary. My family took the news in a different way. Dad diagnosis shook the whole family, but not separate us from him or each other.
The reactions of loved ones a mesothelioma diagnosis
people may react unexpectedly when hearing about a loved one has cancer. Understanding how the loved ones respond to the diagnosis of cancer can help patients to process people may exhibit behaviors.
Dad diagnosis shocked some of our relatives in silence. I do not call or visit. At the time, I did not understand why, and was angry with me.
But now I understand. Their reactions, then, what seems abnormal to me, were completely normal under the circumstances reality. When we are faced with situations that make us uncomfortable, some of us out of the situation as a whole. Others might behave awkwardly or act in a condescending manner.
The American Society of Clinical Oncology, identifies some of the ways family and friends might react to cancer.
Shock: Learning that someone close has cancer can be an unsettling reminder that can happen to anyone. While a diagnosis Most certainly shocks the person with the disease, some loved ones may experience similar emotions.
Painful memories: When someone who has experienced cancer personally or with a loved one, hear about a more recent diagnosis, can recover painful memories. The news can also scare them. Consider your reactions have more to do with his past experiences, not your personal path.
Overwhelmed & Amp; domineering: a cancer diagnosis can be overwhelming to family and friends with concerns, causing their hypervigilant. They may want to see more of you and help you at all times, even if you do not want or need your help.
Finding work through those first awkward encounters engages families and friends of the means of support and benefit for the road ahead. Good communication can help break through these behaviors.
Strong relationships are vital for the proper care of a loved one facing mesothelioma. Social withdrawal and isolation is detrimental to your emotional well-being. From my personal experience, with friends and loved ones for emotional support it is very comforting.
Steps to increase understanding & Amp; acceptance
instead of avoiding a loved one facing cancer, raising their level of acceptance and understanding is generally beneficial.
People who learn about a recent diagnosis loved being must understand some of the physical and emotional changes of patients may experience.
Knowing what to expect when visiting a person with cancer can relieve some stress and shock. The toll cancer in the body is evident shortly after diagnosis. Side effects of cancer treatments, such as alopecia and weight loss, drastically alter the physical appearance.
Because cancer also affects the patient's emotions, your loved one may behave differently than before.
The American Cancer Society offers some tips to ease the stress of the first encounters with recently diagnosed a loved one.
I do not advise your loved one, especially if they are not asking: knowledge and understanding about the disease your loved one does not make you an oncologist. Be respectful and support their decisions.
Do not avoid talking about the disease: cancer Talk about your loved one can travel directly help break the ice and soften it.
Not frequent: Adding an unusual "Honey" or "honey" to your verbal communication can destabilize your loved one. Try to talk and b
Friday, December 11, 2009
Mesothelioma treatments
Keep all your mesothelioma treatments open and watch for the following signs and warnings Change in bowel or bladder habits, a sore that does not heal. Watch for any unusual bleeding or discharge. Thickening or lumps in the breast, testicles or anywhere on the body. If you have indigestion or difficulty swallowing a nagging cough or hoarseness.
Sunday, December 07, 2008
alternative medicines
Mesothelioma Alternative Cancer Treatment
The clinic has treated many peritoneal mesotheliotics who have achieved "remarkable" results.
# A 64 year old gentleman from Buffalo, New York was diagnosed with pleural malignant mesothelioma in early 1998. He underwent the extra-pleural pneumonectomy by Dr. Sugarbaker, followed by three (3) chemotherapy and fifteen (15) radiation treatments in July of 1998. In September, doctors discovered the mesothelioma had spread to his healthy lung. He was given two (2) months to live. He learned of the IAT clinic from his neighbor and traveled to the Bahamas in December. "I should be dead! But here I am! I feel good and I plan on feeling good for a long time."
# A 77 year old gentleman, also from Buffalo, was diagnosed with pleural malignant mesothelioma in September of 1997. He was offered no treatment and given radiation only to the biopsy wound. His family researched the Internet and local libraries in search of alternative treatments. They discovered the IAT clinic while reading about alternative therapies in a book. He traveled to the Bahamas in September of 1998. "I had to quit working because of the mesothelioma. All my life I got up in the morning and went to work." After going to the IAT clinic, he no longer gets tired "just sitting around." He is able to walk his dog, pull weeds in his yard and, as he puts it -- he has been blessed with the privilege of living.
# Cori Harth was first diagnosed with malignant mesothelioma in 1997 at the age of 49. She is continuing to live a strong and active life. "Having been told I probably would not make it to my 50th birthday, and having celebrated my 51st in the Bahamas doing fantastic, I have ample reason to be very thankful. The mesothelioma is no doubt still "there", but between the laetrile and IAT and stem cell, plus continuing my usual juicing, vitamins and minerals, regular exercise, as well as a good attitude, faith and prayer, my immune system is giving the tumor one heck of a run for its money!!!! All I can say is that it is not anecdotal - they treat many different types of cancers there, and believe me, all you would have to do is spend some hours in the clinic talking to patients from all walks of life. And Dr. Clement is totally open to having anyone talk to the patients, and most patients are happy to do so."
# Two men, ages 45 and 38 respectively, who suffered from peritoneal mesothelioma. Both were diagnosed in 1980. The 45 year old underwent conventional chemotherapy (cytoxan, adriamyein, etc.) prior to arriving at the IAT Clinic. The 38 year old had several of the tumors surgically removed. Both started receiving sera treatment in 1980. As of 1988, both reportedly "were in good health." The brochure is undated.
# A 79 year old liver cancer patient from Minnesota who was diagnosed over one year ago. He joked: "I look pretty good for being dead. My doctors gave me six weeks to live. I've been to more places and seen more things than most people, but I was not ready to give up." This patient learned of the clinic from a friend of his ex-wife.
# A 50 year old breast cancer patient from the East Coast. She was diagnosed two years ago. Her doctors gave her no hope for a cure. She learned of the IAT clinic through her veterinarian. We met a 65 year old prostate cancer patient from Colorado who diagnosed in 1990. His urologist told him of the clinic. He is doing very well.
# An 80 year old breast cancer patient from New York. She was diagnosed five years ago and underwent several chemotherapy treatments. Her doctors told her she was to begin radiation treatments as soon as she "got her health back." She did not wait and traveled to the clinic. Now, she is "too busy with my life to find time to play golf, which I love!"
# A 50 year old breast cancer patient from Huntsville, Alabama. She was first diagnosed in 1981 and was told of the clinic by a friend who was being treated for brain cancer. She stopped taking the treatments in 1991. In 1994, she was diagnosed with liver cancer and offered the same conventional treatment as was offered by her doctors in 1981. She went back to the clinic and resumed taking the sera. Today, she is active and leading a "normal" life.
# A 60 year old leukemia patient from New York. She was diagnosed in the early 1970's. In fact, she was the third patient ever treated with the sera by Dr. Burton.
# A doctor from Scotland who is in complete remission after being diagnosed fifteen (15) years ago. A doctor from St. Louis, Missouri was diagnosed with colon cancer eight (8) years ago, a doctor from Seattle, Washington diagnosed with prostate cancer nine (9) years ago. Each was advised by their personal doctors that their tumors were beyond the reach of conventional medicine.
Nowak AK, Lake RA, Kindler HL, Robinson BW. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol. 2002 Feb;29(1):82-96.
University Department of Medicine, University of Western Australia, Verdun St Nedlands, Australia.
Although malignant mesothelioma is not a classically immunogenic cancer, there is abundant evidence for immune recognition. The relative ease of obtaining tumor tissue makes mesothelioma ideal for studying surrogate biomarkers such as lymphocytic infiltration or expression of transduced genes. There is evidence that malignant mesothelioma patients as well as asbestos-exposed persons without mesothelioma have impaired immune responsiveness. Substantial progress has been made in animal models using several biological and immunological techniques, but clinical application has been problematic. Systems studied have included lysis by interleukin-2 (IL-2)-activated lymphokine-activated killer (LAK) cells, tumor necrosis factor-alpha (TNF-alpha), a p16-expressing adenovirus vector, suicide gene therapy using the herpes simplex virus-tyrosine kinase (HSV-tk) followed by ganciclovir, and immunomodulatory gene therapy with IL-2, IL-4, interferon-gamma (IFN-gamma), IFN-alpha, TNF-alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-6, and IL-1beta transfected into tumors. Vaccinia virus has been studied as a vector for cytokine gene transfer. Suicide gene therapy has been combined with a tumor vaccine. The University of Western Australia is initiating a pilot study of autologous vaccination in malignant mesothelioma. Novel agents under study include the angiogenesis inhibitors SU5416, bevacizumab, and thalidomide. ZD1839, an orally administered, highly selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, is being tested in a phase II trial. Since platelet-derived growth factor (PDGF) is thought to be an autocrine growth factor for mesothelioma STI-571 (Gleevec; Novartis, Basel, Switzerland), a highly selective inhibitor of the PDGF receptor tyrosine kinase, is being tested in a phase II trial. The development of more active cytotoxic combinations in this disease should facilitate further studies of chemoimmunotherapy. It seems likely that no single treatment modality will be effective by itself. Copyright 2002 by W.B. Saunders Company.
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Cancer Res. 2001 Aug 15;61(16):6201-12.
Odaka M, Sterman DH, Wiewrodt R, Zhang Y, Kiefer M, Amin KM, Gao GP, Wilson JM, Barsoum J, Kaiser LR, Albelda SM. Thoracic Oncology Research Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA.
Malignant mesothelioma remains an incurable disease for which immune-modulatory therapies, such as exogenous cytokines, have shown some promise. One such cytokine, IFN-beta, has potent antiproliferative and immunostimulatory activity in vitro, but its in vivo use has been limited by toxicity. We thus conducted studies evaluating intracavitary delivery of a replication-deficient adenoviral (Ad) vector encoding for the murine IFN-beta gene (Ad.muIFN-beta) in mouse models of malignant mesothelioma. In contrast to multiple injections of recombinant protein, a single i.p. injection of Ad.muIFN-beta into animals with established tumors elicited remarkable antitumor activity leading to long-term survival in >90% of animals bearing either AB12 or AC29 i.p. mesotheliomas. A control adenovirus vector had minimal antitumor effect in vivo. Significant therapeutic effects were also seen in animals treated with large tumor burdens. Importantly, treatment of i.p. tumor also led to reduction of growth in tumors established at a distant site (flank). A number of experiments suggested that these effects were attributable to an acquired CD8(+) T-cell-mediated response including: (a) the induction of long-lasting antitumor immunity; (b) loss of efficacy of Ad.muIFN-beta in tumor-bearing, immune-deficient (SCID, SCID/beige) mice; (c) detection of high levels of specific antitumor cytolytic activity from unstimulated splenocytes harvested from Ad.muIFN-beta-treated animals that was abolished by CD8(+) T-cell depletion; and (d) abrogation of antitumor effects of Ad.muIFN-beta in tumor-bearing CD8(+) T-cell-depleted animals. These data show that intracavitary IFN-beta gene therapy using an adenoviral vector provides strong CD8(+) T-cell-mediated antitumor effects in murine models of mesothelioma and suggest that this may be a promising strategy for the treatment of localized tumors such as mesothelioma or ovarian cancer in humans.
The clinic has treated many peritoneal mesotheliotics who have achieved "remarkable" results.
# A 64 year old gentleman from Buffalo, New York was diagnosed with pleural malignant mesothelioma in early 1998. He underwent the extra-pleural pneumonectomy by Dr. Sugarbaker, followed by three (3) chemotherapy and fifteen (15) radiation treatments in July of 1998. In September, doctors discovered the mesothelioma had spread to his healthy lung. He was given two (2) months to live. He learned of the IAT clinic from his neighbor and traveled to the Bahamas in December. "I should be dead! But here I am! I feel good and I plan on feeling good for a long time."
# A 77 year old gentleman, also from Buffalo, was diagnosed with pleural malignant mesothelioma in September of 1997. He was offered no treatment and given radiation only to the biopsy wound. His family researched the Internet and local libraries in search of alternative treatments. They discovered the IAT clinic while reading about alternative therapies in a book. He traveled to the Bahamas in September of 1998. "I had to quit working because of the mesothelioma. All my life I got up in the morning and went to work." After going to the IAT clinic, he no longer gets tired "just sitting around." He is able to walk his dog, pull weeds in his yard and, as he puts it -- he has been blessed with the privilege of living.
# Cori Harth was first diagnosed with malignant mesothelioma in 1997 at the age of 49. She is continuing to live a strong and active life. "Having been told I probably would not make it to my 50th birthday, and having celebrated my 51st in the Bahamas doing fantastic, I have ample reason to be very thankful. The mesothelioma is no doubt still "there", but between the laetrile and IAT and stem cell, plus continuing my usual juicing, vitamins and minerals, regular exercise, as well as a good attitude, faith and prayer, my immune system is giving the tumor one heck of a run for its money!!!! All I can say is that it is not anecdotal - they treat many different types of cancers there, and believe me, all you would have to do is spend some hours in the clinic talking to patients from all walks of life. And Dr. Clement is totally open to having anyone talk to the patients, and most patients are happy to do so."
# Two men, ages 45 and 38 respectively, who suffered from peritoneal mesothelioma. Both were diagnosed in 1980. The 45 year old underwent conventional chemotherapy (cytoxan, adriamyein, etc.) prior to arriving at the IAT Clinic. The 38 year old had several of the tumors surgically removed. Both started receiving sera treatment in 1980. As of 1988, both reportedly "were in good health." The brochure is undated.
# A 79 year old liver cancer patient from Minnesota who was diagnosed over one year ago. He joked: "I look pretty good for being dead. My doctors gave me six weeks to live. I've been to more places and seen more things than most people, but I was not ready to give up." This patient learned of the clinic from a friend of his ex-wife.
# A 50 year old breast cancer patient from the East Coast. She was diagnosed two years ago. Her doctors gave her no hope for a cure. She learned of the IAT clinic through her veterinarian. We met a 65 year old prostate cancer patient from Colorado who diagnosed in 1990. His urologist told him of the clinic. He is doing very well.
# An 80 year old breast cancer patient from New York. She was diagnosed five years ago and underwent several chemotherapy treatments. Her doctors told her she was to begin radiation treatments as soon as she "got her health back." She did not wait and traveled to the clinic. Now, she is "too busy with my life to find time to play golf, which I love!"
# A 50 year old breast cancer patient from Huntsville, Alabama. She was first diagnosed in 1981 and was told of the clinic by a friend who was being treated for brain cancer. She stopped taking the treatments in 1991. In 1994, she was diagnosed with liver cancer and offered the same conventional treatment as was offered by her doctors in 1981. She went back to the clinic and resumed taking the sera. Today, she is active and leading a "normal" life.
# A 60 year old leukemia patient from New York. She was diagnosed in the early 1970's. In fact, she was the third patient ever treated with the sera by Dr. Burton.
# A doctor from Scotland who is in complete remission after being diagnosed fifteen (15) years ago. A doctor from St. Louis, Missouri was diagnosed with colon cancer eight (8) years ago, a doctor from Seattle, Washington diagnosed with prostate cancer nine (9) years ago. Each was advised by their personal doctors that their tumors were beyond the reach of conventional medicine.
Nowak AK, Lake RA, Kindler HL, Robinson BW. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol. 2002 Feb;29(1):82-96.
University Department of Medicine, University of Western Australia, Verdun St Nedlands, Australia.
Although malignant mesothelioma is not a classically immunogenic cancer, there is abundant evidence for immune recognition. The relative ease of obtaining tumor tissue makes mesothelioma ideal for studying surrogate biomarkers such as lymphocytic infiltration or expression of transduced genes. There is evidence that malignant mesothelioma patients as well as asbestos-exposed persons without mesothelioma have impaired immune responsiveness. Substantial progress has been made in animal models using several biological and immunological techniques, but clinical application has been problematic. Systems studied have included lysis by interleukin-2 (IL-2)-activated lymphokine-activated killer (LAK) cells, tumor necrosis factor-alpha (TNF-alpha), a p16-expressing adenovirus vector, suicide gene therapy using the herpes simplex virus-tyrosine kinase (HSV-tk) followed by ganciclovir, and immunomodulatory gene therapy with IL-2, IL-4, interferon-gamma (IFN-gamma), IFN-alpha, TNF-alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-6, and IL-1beta transfected into tumors. Vaccinia virus has been studied as a vector for cytokine gene transfer. Suicide gene therapy has been combined with a tumor vaccine. The University of Western Australia is initiating a pilot study of autologous vaccination in malignant mesothelioma. Novel agents under study include the angiogenesis inhibitors SU5416, bevacizumab, and thalidomide. ZD1839, an orally administered, highly selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, is being tested in a phase II trial. Since platelet-derived growth factor (PDGF) is thought to be an autocrine growth factor for mesothelioma STI-571 (Gleevec; Novartis, Basel, Switzerland), a highly selective inhibitor of the PDGF receptor tyrosine kinase, is being tested in a phase II trial. The development of more active cytotoxic combinations in this disease should facilitate further studies of chemoimmunotherapy. It seems likely that no single treatment modality will be effective by itself. Copyright 2002 by W.B. Saunders Company.
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity. Cancer Res. 2001 Aug 15;61(16):6201-12.
Odaka M, Sterman DH, Wiewrodt R, Zhang Y, Kiefer M, Amin KM, Gao GP, Wilson JM, Barsoum J, Kaiser LR, Albelda SM. Thoracic Oncology Research Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA.
Malignant mesothelioma remains an incurable disease for which immune-modulatory therapies, such as exogenous cytokines, have shown some promise. One such cytokine, IFN-beta, has potent antiproliferative and immunostimulatory activity in vitro, but its in vivo use has been limited by toxicity. We thus conducted studies evaluating intracavitary delivery of a replication-deficient adenoviral (Ad) vector encoding for the murine IFN-beta gene (Ad.muIFN-beta) in mouse models of malignant mesothelioma. In contrast to multiple injections of recombinant protein, a single i.p. injection of Ad.muIFN-beta into animals with established tumors elicited remarkable antitumor activity leading to long-term survival in >90% of animals bearing either AB12 or AC29 i.p. mesotheliomas. A control adenovirus vector had minimal antitumor effect in vivo. Significant therapeutic effects were also seen in animals treated with large tumor burdens. Importantly, treatment of i.p. tumor also led to reduction of growth in tumors established at a distant site (flank). A number of experiments suggested that these effects were attributable to an acquired CD8(+) T-cell-mediated response including: (a) the induction of long-lasting antitumor immunity; (b) loss of efficacy of Ad.muIFN-beta in tumor-bearing, immune-deficient (SCID, SCID/beige) mice; (c) detection of high levels of specific antitumor cytolytic activity from unstimulated splenocytes harvested from Ad.muIFN-beta-treated animals that was abolished by CD8(+) T-cell depletion; and (d) abrogation of antitumor effects of Ad.muIFN-beta in tumor-bearing CD8(+) T-cell-depleted animals. These data show that intracavitary IFN-beta gene therapy using an adenoviral vector provides strong CD8(+) T-cell-mediated antitumor effects in murine models of mesothelioma and suggest that this may be a promising strategy for the treatment of localized tumors such as mesothelioma or ovarian cancer in humans.
Thursday, August 07, 2008
breaking news
was announced today that in a monumental move, ABC, CBS, and NBC will collaborate to air a telethon on September 5 featuring a collection of celebrities. The hour-long special is a fundraiser for cancer research and has been termed "Stand Up to Cancer."
The telethon will include musical performances and appearances from actors, athletes, and journalists. Viewers will be invited to donate by calling the celebrity-staffed phone bank or by texting. This sort of collaborative event is rare but not unprecedented. In recent years, similar fundraisers have been hosted for victims of Hurricane Katrina and September 11th.
Stand Up to Cancer will feature such celebrities as Meryl Streep, Lance Armstrong, Forest Whitaker, Charlize Theron, Hilary Swank, America Ferrera, Danica Patrick, Salma Hayek, Kirsten Dunst, Josh Brolin, Scarlett Johansson, Jennifer Aniston, Masi Oka and news anchors Charles Gibson, Brian Williams and Katie Couric. The list is expected to grow as the event nears.
FOX was invited to join the telethon, but declined so as to focus on their own global outreach project, "Idol Gives Back," centered around American Idol stars. FOX will promote Stand Up to Cancer by airing public service announcements for the event.
According to the Associated Press, "The telethon is part of a broader initiative aimed at raising money to quicken the pace of research leading to development of new treatments. The effort is to be administered by the American Association for Cancer Research under the direction of a committee led by Phillip A. Sharp of the David H. Koch Institute for Integrative Cancer Research at MIT."
The telethon will include musical performances and appearances from actors, athletes, and journalists. Viewers will be invited to donate by calling the celebrity-staffed phone bank or by texting. This sort of collaborative event is rare but not unprecedented. In recent years, similar fundraisers have been hosted for victims of Hurricane Katrina and September 11th.
Stand Up to Cancer will feature such celebrities as Meryl Streep, Lance Armstrong, Forest Whitaker, Charlize Theron, Hilary Swank, America Ferrera, Danica Patrick, Salma Hayek, Kirsten Dunst, Josh Brolin, Scarlett Johansson, Jennifer Aniston, Masi Oka and news anchors Charles Gibson, Brian Williams and Katie Couric. The list is expected to grow as the event nears.
FOX was invited to join the telethon, but declined so as to focus on their own global outreach project, "Idol Gives Back," centered around American Idol stars. FOX will promote Stand Up to Cancer by airing public service announcements for the event.
According to the Associated Press, "The telethon is part of a broader initiative aimed at raising money to quicken the pace of research leading to development of new treatments. The effort is to be administered by the American Association for Cancer Research under the direction of a committee led by Phillip A. Sharp of the David H. Koch Institute for Integrative Cancer Research at MIT."
Friday, June 06, 2008
Quick Facts
MESOTHELIOMA QUICK FACTS
It is estimated that 27.5 million Americans were exposed to asbestos between 1940 and 1979.
The first known asbestos lawsuit was in 1929 in New Jersey.
About 4,000 People die from Mesothelioma every year, the rare cancer caused by asbestos exposure.
It is estimated that 27.5 million Americans were exposed to asbestos between 1940 and 1979.
Mesothelioma has a latency period of 20 to 50 years after the first exposure to asbestos.
It is estimated that there will be about 250,000 cases of Mesothelioma before 2020.
There are currently about 3000 new cases of Mesothelioma diagnosed per year, mostly in men over the age of 40.
Many asbestos-containing products remain in buildings, ships, industrial facilities and other environments where the fibers can become airborne.
During the 20th century, some 30 million tons of asbestos were used in industrial sites, homes, schools, shipyards and commercial buildings in the U. S.
The name Asbestos was given to this mineral by the Ancient Greeks. The word “Asbestos” literally means inextinguishable.
It has been well known for many years that asbestos exposure can result in the development of deadly cancers, particularly Mesothelioma.
In the mid 1920s, an English doctor made the first diagnosis of asbestosis, and this was followed by a study which showed that 25% of English asbestos workers showed signs of a related lung disease.
Through 2003, more than 700,000 People have filed claims against more than 6,000 Asbestos companies. These same companies knew of the dangers for many years before ever warning the public of those risks.
It is thought that around eight million people in the United States have been exposed to asbestos over the past half a century, and many more cases - are expected to be reported in the next 25 years.
The National Institute of Health in 1978 estimated that eight to eleven million U.S. workers had been exposed to asbestos by that date. In fact, by 1970, it is estimated that some 25 million tons of asbestos were used in the U.S.
Mesothelioma is a disease that is almost 100% preventable; the only known cause is via exposure to the deadly mineral Asbestos . It comes from inhaling the particles of dust as the asbestos degrades; eating away at the lining of your lungs and developing into a deadly cancer.
It is estimated that 27.5 million Americans were exposed to asbestos between 1940 and 1979.
The first known asbestos lawsuit was in 1929 in New Jersey.
About 4,000 People die from Mesothelioma every year, the rare cancer caused by asbestos exposure.
It is estimated that 27.5 million Americans were exposed to asbestos between 1940 and 1979.
Mesothelioma has a latency period of 20 to 50 years after the first exposure to asbestos.
It is estimated that there will be about 250,000 cases of Mesothelioma before 2020.
There are currently about 3000 new cases of Mesothelioma diagnosed per year, mostly in men over the age of 40.
Many asbestos-containing products remain in buildings, ships, industrial facilities and other environments where the fibers can become airborne.
During the 20th century, some 30 million tons of asbestos were used in industrial sites, homes, schools, shipyards and commercial buildings in the U. S.
The name Asbestos was given to this mineral by the Ancient Greeks. The word “Asbestos” literally means inextinguishable.
It has been well known for many years that asbestos exposure can result in the development of deadly cancers, particularly Mesothelioma.
In the mid 1920s, an English doctor made the first diagnosis of asbestosis, and this was followed by a study which showed that 25% of English asbestos workers showed signs of a related lung disease.
Through 2003, more than 700,000 People have filed claims against more than 6,000 Asbestos companies. These same companies knew of the dangers for many years before ever warning the public of those risks.
It is thought that around eight million people in the United States have been exposed to asbestos over the past half a century, and many more cases - are expected to be reported in the next 25 years.
The National Institute of Health in 1978 estimated that eight to eleven million U.S. workers had been exposed to asbestos by that date. In fact, by 1970, it is estimated that some 25 million tons of asbestos were used in the U.S.
Mesothelioma is a disease that is almost 100% preventable; the only known cause is via exposure to the deadly mineral Asbestos . It comes from inhaling the particles of dust as the asbestos degrades; eating away at the lining of your lungs and developing into a deadly cancer.
Friday, January 18, 2008
Subscribe to:
Comments (Atom)